$Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization$
QR Code

QR Code

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization

Aim. To evaluate prediction role of the biomarkers soluble ST2 (sST2) and natriuretic hormone N-terminal propeptide (NT-proBNP) in risk assessment of adverse cardiovascular events (ACVE) in coronary heart disease patients (CHD) with chronic heart failure (CHF) after myocardial revascularization.Mate...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease myocardial revascularization adverse cardiovascular events prediction biomarkers heart failure
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/755
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
by: E. V. Grakova, et al.
Published: (2019-09-01)

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction
by: E. V. Grakova, et al.
Published: (2022-04-01)

EFFICACY OF MYOCARDIAL REVASCULARIZATION IN POTENTIAL RECIPIENTS OF HEART WITH THE CHRONIC ISCHEMIC HEART FAILURE
by: S. V. Gautier, et al.
Published: (2018-04-01)

EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE
by: A. B. Mironkov, et al.
Published: (2017-01-01)

Current state of myocardial revascularization in patients with severe left ventricular systolic dysfunction
by: S. V. Gautier, et al.
Published: (2017-04-01)

Meta-analyses and systematic reviews on myocardial revascularization: comparing survival, myocardial infarction, repeated revascularization and angina symptom reduction rates
by: I. V. Samorodskaya
Published: (1970-01-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)

Radiofrequency transmyocardial revascularization in experiment
by: A. I. Opherkin, et al.
Published: (2002-09-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

Arrhythmias in Patients after Surgical Myocardial Revascularization
by: N. U. Zakirov, et al.
Published: (2020-03-01)

Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome
by: A. T. Teplyakov, et al.
Published: (2021-07-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

Gender-specific characteristics of heart failure with preserved ejection fraction in women: focus on pregnancy factors
by: M. I. Shperling, et al.
Published: (2024-09-01)

MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: PROBLEM STATEMENT
by: A. B. Mironkov
Published: (2013-05-01)

The choice of revascularization method in patients with multivessel disease based on evidence-based medicine (literature review)
by: T. V. Ogir, et al.
Published: (2021-06-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction
by: A. V. Оsokina, et al.
Published: (2021-09-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Heart failure with preserved ejection fraction: the role of microvascular dysfunction
by: K. V. Kopeva, et al.
Published: (2023-01-01)

Evaluation of ST2 as an early marker of heart failure with a preserved left ventricular ejection fraction in patients with persistent atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2020-02-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta‐Analysis
by: Vinayak Nagaraja, et al.
Published: (2016-12-01)

The results of standard echocardiography and use of Velocity Vector Imaging technology after surgical revascularization in patients with coronary artery disease
by: A. Yu. Vasiliev, et al.
Published: (2019-08-01)

A DECADE OF EXPERIENCE IN APPLICATION OF TRANSMYOCARDIAL LASER REVASCULARIZATION IN COMBINATION WITH AORTOCORONARY SHUNTING
by: A. V. Krnchoyan, et al.
Published: (2020-03-01)

Principles for diagnosing heart failure with preserved ejection fraction
by: N. E. Shirokov, et al.
Published: (2023-09-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Prevalence and Prognostic Value of the Novel Consensus Definition of Metabolic Hyperferritinemia in Patients With Heart Failure With Preserved Ejection Fraction Across Different Glucose Metabolism States
by: Weicheng Ni, et al.
Published: (2025-07-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Left atrial to coronary sinus shunting in more advanced heart failure with preserved ejection fraction
by: Ryan J. Tedford, et al.
Published: (2025-08-01)

The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium
by: O. A. Yepanchintseva, et al.
Published: (2020-11-01)

Minimally invasive myocardial revascularization in left coronary artery trunk pathology: safety, efficacy, and clinical results
by: M. V. Zhelikhazheva, et al.
Published: (2005-10-01)

TExtravasal myocardial revascularization in complex treatment of patients with ischemic heart disease: historical background and modern condition
by: G. G. Borshev
Published: (2015-06-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)